← All stocks

ORAMED PHARMACEUTICALS INC.

ORMP No buying or selling
CIK 0001176309 #3940 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

9 insiders · 0 transactions
24.9×

Nadav Kidron holds 24.9 times base salary in stock. $15.43M of shares against $619.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Nadav Kidron last reported holding, valued at $4.51, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
KIDRON NADAV
President and CEO
3,422,243
$15.43M
+87.4%
Kidron Miriam
Chief Scientific Officer
1,133,138
$5.11M
+33.3%
Hexter Joshua
COO & CBO
1,073,384
$4.84M
+122.8%
Gabay Avraham
Chief Financial Officer
671,785
$3.03M
+379.7%
Mayer Arie
Director
168,009
$757.47K
+74.8%
Sank Leonard
Director
134,531
$606.53K
+37.2%
Shapiro Benjamin
Director
123,220
$555.54K
+123.8%
Aghion Daniel
Director
113,441
$511.45K
+192.2%
Reznick Yehuda
Director
105,180
$474.20K
+244.2%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 7 Nov 2016